Bladder Cancer

  • Dayssy A. Diaz
  • Alan Pollack
  • Matthew C. Abramowitz


Bladder preservation therapy multimodal with concurrent chemotherapy and radiotherapy. Bladder preservation is a treatment option primarily for patients with clinical T2 or T3a disease, no ureteral obstruction, complete transurethral resection of bladder tumor (TURBT), and regionally localized tumor


Bladder Cancer Bladder Tumor Concurrent Chemotherapy Ureteral Obstruction Bladder Filling 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Shipley WU, Prout GR Jr, Einstein AB et al (1987) Treatment of invasive bladder cancer by cisplatin and radiation in patients unsuited for surgery. JAMA 258:931–935PubMedCrossRefGoogle Scholar
  2. 2.
    Shipley WU, Winter KA, Kaufman DS et al (1998) Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of Radiation Therapy Oncology Group 89–03. J Clin Oncol 16:3576–3583PubMedGoogle Scholar
  3. 3.
    Tester W, Porter A, Asbell S et al (1993) Combined modality program with possible organ preservation for invasive bladder carcinoma: results of RTOG protocol 85–12. Int J Radiat Oncol Biol Phys 25:783–790PubMedCrossRefGoogle Scholar
  4. 4.
    Rodel C, Grabenbauer GG, Kuhn R et al (2002) Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results. J Clin Oncol 20:3061–3071PubMedCrossRefGoogle Scholar
  5. 5.
    Kaufman DS, Winter KA, Shipley WU et al (2009) Phase I-II RTOG study (99–06) of patients with muscle-invasive bladder cancer undergoing transurethral surgery, paclitaxel, cisplatin, and twice-daily radiotherapy followed by selective bladder preservation or radical cystectomy and adjuvant chemotherapy. Urology 73:833–837PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • Dayssy A. Diaz
    • 1
  • Alan Pollack
    • 1
  • Matthew C. Abramowitz
    • 1
  1. 1.Department of Radiation Oncology, Sylvester Comprehensive Cancer CenterUniversity of Miami, Miller School of MedicineMiamiUSA

Personalised recommendations